Search results
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 12 hours agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA TODAY via Yahoo News· 2 days agoDuring the Vaccines and Related...health experts from vaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were ...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 5 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 19 hours agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 3 days agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 6 days agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun via Yahoo News· 5 hours agoVaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were prepared to make JN.1-targeted vaccines available in ...
Moderna Falls, Though Says Covid/Flu Shot Topped Rivals
Investor's Business Daily· 4 days agoIn a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 4 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...